Peptide therapy. Without the bullshit.

Physician-supervised. U.S.-compounded. Third-party tested on every batch. And we'll tell you upfront if it's not right for you.

If you've done GLP-1s, you already know how this works. Same model, different molecules.

Turritopsis dohrnii jellyfish glowing in deep water
“FDA testing found 40% of peptides sold by research-chemical vendors had inaccurate dosing, contamination, or degradation. Ours don't.”
01

Lot-level potency testing

Every batch is assayed for actual peptide content against label claim. No assumptions.

02

Sterility & endotoxin testing

Compounded by 503A and 503B pharmacies under USP <797> sterile conditions, with each lot screened before release.

03

Third-party verification

Independent labs confirm identity, purity, and stability. We publish certificates of analysis on request.

What we do differently

We tell you what we don't know.

Peptide research is uneven. On every peptide page, we mark evidence quality and call out where the data thins out.

Read the peptide library

We lead with who shouldn't use this.

Contraindications go above benefits — not buried in fine print. If a peptide isn't right for you, we'd rather you find out now.

See contraindications

We publish our drug interaction guidance.

Our clinical team's interaction notes are public, not paywalled behind an intake form. Bring them to your prescriber.

Read interaction guidance

How it works

  1. 01

    Take the quiz

    Two minutes. Health history, goals, current medications. No account required to find out if you qualify.

  2. 02

    Physician consult

    A licensed U.S. physician reviews your intake and meets you over video to discuss what's appropriate.

  3. 03

    Bloodwork + first prescription

    Baseline labs at a local draw site. If cleared, your prescription ships from a vetted compounding pharmacy.

  4. 04

    Ongoing monitoring with labs

    Quarterly check-ins and repeat labs. We adjust the protocol — or stop it — based on what your body actually does.

Licensed U.S. physicians
503B-pharmacy option
Third-party batch tested
LegitScript certified

From the Journal

All essays →
March 2026 · Evidence

What FDA testing actually found about online peptides

A plain-language read of the FDA's market surveillance data — what was contaminated, what was underdosed, and what to look for on a label.

Read →
February 2026 · Protocols

You finished GLP-1s. Here's what some people do next.

Many of our patients arrive after semaglutide or tirzepatide. We walk through the most common next steps — and the ones we'd push back on.

Read →
January 2026 · Safety

Who shouldn't take peptides — and why we're glad to tell you

Active cancer. Pregnancy. Certain endocrine conditions. We'd rather lose a sale than ship the wrong protocol to the wrong person.

Read →

Ready to find out if this is right for you?

The quiz takes 2 minutes. If you don't qualify, we'll tell you that too.